Comparative Pharmacology
Head-to-head clinical analysis: CLONAZEPAM versus LOREEV XR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLONAZEPAM versus LOREEV XR.
CLONAZEPAM vs LOREEV XR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Enhances GABA-A receptor inhibitory neurotransmission by binding to benzodiazepine binding site, increasing frequency of chloride channel opening, leading to neuronal hyperpolarization.
Levetiracetam is a racetam anticonvulsant that binds to synaptic vesicle glycoprotein 2A (SV2A), reducing neurotransmitter release and neuronal excitability. It also inhibits N-type calcium channels and modulates GABAergic and glutamatergic transmission.
0.5 mg orally three times daily; maximum 20 mg/day
50 mg orally once daily, preferably in the evening. Maximum dose 100 mg/day.
None Documented
None Documented
Terminal elimination half-life: 19-60 hours (mean 30-40 hours); clinical context: long-acting benzodiazepine, allows once or twice daily dosing; accumulation occurs with repeated use.
Clinical Note
moderateClonazepam + Sulfisoxazole
"The metabolism of Sulfisoxazole can be decreased when combined with Clonazepam."
Clinical Note
moderateClonazepam + Erythromycin
"The metabolism of Erythromycin can be decreased when combined with Clonazepam."
Clinical Note
moderateClonazepam + Cyclosporine
"The metabolism of Cyclosporine can be decreased when combined with Clonazepam."
Clinical Note
moderateClonazepam + Fluconazole
Terminal elimination half-life is 6-8 hours in healthy adults; prolonged in renal impairment (up to 16 hours in severe impairment).
Renal: 50-70% as metabolites (mostly glucuronide conjugates), <2% unchanged; fecal: 10-20%; biliary: minor.
Renal excretion of unchanged drug accounts for approximately 70% of elimination; fecal excretion accounts for approximately 30%, primarily as metabolites.
Category D/X
Category C
Benzodiazepine
Benzodiazepine
"The metabolism of Fluconazole can be decreased when combined with Clonazepam."